Bexarotene
NDC 0832-0285, Bexarotene, capsule, from Upsher-Smith Laboratories, Inc..
- Product NDC
- 0832-0285
- Status
- Listed
- Labeler
- Upsher-Smith Laboratories, Inc.
- Dosage form
- CAPSULE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA209886
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0832-0285 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- BEXAROTENE75 mg/1
Pharmacologic classes
Retinoid [EPC]; Retinoids [CS]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0832-0285-00 | 00832028500 | 100 CAPSULE in 1 BOTTLE (0832-0285-00) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/7437a43f-172a-4f4e-8132-fe23b00224f9
Use it
Look up 0832-0285 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0832-0285 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0832-0285. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.